Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 428

1.

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.

Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1194-9.

2.

Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE.

Arch Neurol. 2004 Mar;61(3):378-84.

PMID:
15023815
3.

Education modifies the relation of AD pathology to level of cognitive function in older persons.

Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL.

Neurology. 2003 Jun 24;60(12):1909-15.

PMID:
12821732
4.

Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.

Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE.

J Am Geriatr Soc. 2009 Mar;57(3):427-31. doi: 10.1111/j.1532-5415.2008.02129.x.

PMID:
19278396
5.

Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.

Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ.

Neurology. 2002 Jun 11;58(11):1629-34.

PMID:
12058090
6.

Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.

Reed T, Carmelli D, Swan GE, Breitner JC, Welsh KA, Jarvik GP, Deeb S, Auwerx J.

Arch Neurol. 1994 Dec;51(12):1189-92.

PMID:
7986172
7.

Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.

Levy JA, Bergeson J, Putnam K, Rosen V, Cohen R, Lalonde F, Mirza N, Linker G, Sunderland T.

J Int Neuropsychol Soc. 2004 May;10(3):362-70.

PMID:
15147594
8.

Apolipoprotein E and cognitive change in an elderly population.

Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R.

Ann Neurol. 1996 Jul;40(1):55-66.

PMID:
8687193
9.

Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.

Traykov L, Rigaud AS, Baudic S, Smagghe A, Boller F, Forette F.

J Neurol Sci. 2002 Nov 15;203-204:177-81.

PMID:
12417380
10.

Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study.

Winnock M, Letenneur L, Jacqmin-Gadda H, Dallongeville J, Amouyel P, Dartigues JF.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):794-7.

11.

APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.

Butters MA, Sweet RA, Mulsant BH, Ilyas Kamboh M, Pollock BG, Begley AE, Reynolds CF 3rd, DeKosky ST.

Int J Geriatr Psychiatry. 2003 Dec;18(12):1075-81.

PMID:
14677138
12.

Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease.

Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, Han LY, Bienias JL, Lee VM, Trojanowski JQ, Bennett DA, Arnold SE.

Ann Neurol. 2002 Feb;51(2):182-9.

PMID:
11835374
13.

Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.

Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H.

Brain. 2008 May;131(Pt 5):1252-8. doi: 10.1093/brain/awn034. Epub 2008 Mar 11.

PMID:
18334538
14.

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.

Dement Geriatr Cogn Disord. 2007;24(2):98-103. Epub 2007 Jun 26.

PMID:
17596691
15.

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL.

Neurology. 2003 Jan 28;60(2):246-52.

PMID:
12552039
16.

Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.

Ohm TG, Kirca M, Bohl J, Scharnagl H, Gross W, März W.

Neuroscience. 1995 Jun;66(3):583-7.

PMID:
7644022
17.
18.

A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.

Mauricio M, O'Hara R, Yesavage JA, Friedman L, Kraemer HC, Van De Water M, Murphy GM Jr.

Am J Geriatr Psychiatry. 2000 Summer;8(3):196-200.

PMID:
10910416
19.

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

Strozyk D, Blennow K, White LR, Launer LJ.

Neurology. 2003 Feb 25;60(4):652-6.

PMID:
12601108
20.

Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.

Beffert U, Poirier J.

Ann N Y Acad Sci. 1996 Jan 17;777:166-74.

PMID:
8624080

Supplemental Content

Support Center